{"hands_on_practices": [{"introduction": "Understanding hypertensive disorders of pregnancy requires moving beyond simple blood pressure readings to grasp the underlying hemodynamics. While elevated blood pressure is the defining sign, the true pathology often lies in compromised organ perfusion. This exercise ([@problem_id:4451724]) challenges you to connect the fundamental concepts of mean arterial pressure ($MAP$), which represents the average perfusion pressure, and vascular resistance to explain the central paradox of preeclampsia: how uteroplacental blood flow can be critically reduced despite systemic hypertension.", "problem": "A gravida $2$, para $1$ patient at $32$ weeks of gestation is evaluated in a prenatal clinic for elevated blood pressure. After $5$ minutes of seated rest, three oscillometric measurements taken at $1$-minute intervals yield consistent systolic blood pressure and diastolic blood pressure values averaging $\\text{Systolic Blood Pressure (SBP)}=150\\,\\text{mmHg}$ and $\\text{Diastolic Blood Pressure (DBP)}=95\\,\\text{mmHg}$. For purposes of hemodynamic reasoning, use the following foundational bases without introducing any shortcut formulas:\n- The instantaneous arterial pressure over one cardiac cycle of duration $T$ has a time-average defined as $\\text{Mean Arterial Pressure (MAP)}=\\frac{1}{T}\\int_{0}^{T} P(t)\\,\\mathrm{d}t$.\n- At resting heart rates typical of late pregnancy, systole occupies approximately one-third of the cardiac cycle and diastole approximately two-thirds.\n- In a simplified teaching model, the arterial pressure during systole can be treated as approximately constant at $SBP$, and during diastole as approximately constant at $DBP$.\n- Uteroplacental blood flow (UPBF) obeys an Ohm-type relation $UPBF \\approx \\frac{P_{ua}-P_{uv}}{\\text{Uterine Vascular Resistance (UVR)}}$, where $P_{ua}$ is uterine arterial pressure and $P_{uv}$ is uterine venous pressure; in the absence of significant venous outflow obstruction, $P_{uv}$ is assumed unchanged, and $P_{ua}$ is approximated by $MAP$. Hypertensive disorders of pregnancy are characterized by increased systemic and uterine vascular resistance due to endothelial dysfunction and vasoconstriction.\n\nTasks:\n1. Using only the time-averaging definition and the systole/diastole time-fraction assumptions stated above, derive an expression for $MAP$ in terms of $SBP$ and $DBP$, and then compute the exact $MAP$ for this patient from the given $SBP$ and $DBP$. Express $MAP$ in millimeters of mercury ($\\text{mmHg}$). Provide the exact value; do not round.\n2. Briefly, on the basis of the hemodynamic relation for $UPBF$ and the pathophysiology of hypertensive disorders of pregnancy, interpret whether the patient’s uteroplacental perfusion is expected to be increased or decreased relative to a normotensive pregnancy, and explain why, making explicit the roles of perfusion pressure and vascular resistance. You may, if helpful, reference the diagnostic thresholds for hypertensive disorders in pregnancy (sustained $SBP \\geq 140\\,\\text{mmHg}$ or $DBP \\geq 90\\,\\text{mmHg}$, with severe range $SBP \\geq 160\\,\\text{mmHg}$ or $DBP \\geq 110\\,\\text{mmHg}$), but your quantitative answer in part $1$ must stand alone.", "solution": "The problem is assessed as valid. It is scientifically grounded in established principles of cardiovascular physiology, well-posed with sufficient and consistent information, and phrased in objective, formal language. The model presented is a standard, albeit simplified, representation used for pedagogical purposes in biophysics and medicine.\n\n**Part 1: Derivation and Calculation of Mean Arterial Pressure (MAP)**\n\nThe problem defines the Mean Arterial Pressure ($MAP$) as the time-average of the instantaneous arterial pressure, $P(t)$, over one cardiac cycle of duration $T$:\n$$\n\\text{MAP} = \\frac{1}{T} \\int_{0}^{T} P(t) \\, \\mathrm{d}t\n$$\nThe problem provides a simplified model for the pressure waveform $P(t)$. It states that for a cardiac cycle of duration $T$, systole occupies a duration of $\\frac{1}{3}T$ and diastole occupies the remaining duration of $\\frac{2}{3}T$. Within these intervals, the pressure is assumed to be constant:\n- During systole (duration $\\frac{T}{3}$): $P(t) = \\text{Systolic Blood Pressure (SBP)}$\n- During diastole (duration $\\frac{2T}{3}$): $P(t) = \\text{Diastolic Blood Pressure (DBP)}$\n\nUsing these assumptions, we can evaluate the integral by splitting it into two parts corresponding to systole and diastole:\n$$\n\\int_{0}^{T} P(t) \\, \\mathrm{d}t = \\int_{\\text{systole}} P(t) \\, \\mathrm{d}t + \\int_{\\text{diastole}} P(t) \\, \\mathrm{d}t\n$$\nSubstituting the constant pressure values and the respective time durations:\n$$\n\\int_{0}^{T} P(t) \\, \\mathrm{d}t = (\\text{SBP}) \\times \\left(\\frac{1}{3}T\\right) + (\\text{DBP}) \\times \\left(\\frac{2}{3}T\\right)\n$$\nNow, we substitute this result back into the definition of $MAP$:\n$$\n\\text{MAP} = \\frac{1}{T} \\left[ (\\text{SBP}) \\times \\left(\\frac{T}{3}\\right) + (\\text{DBP}) \\times \\left(\\frac{2T}{3}\\right) \\right]\n$$\nThe cardiac cycle duration $T$ cancels from the expression:\n$$\n\\text{MAP} = \\frac{1}{3}\\text{SBP} + \\frac{2}{3}\\text{DBP}\n$$\nThis is the derived expression for $MAP$ based on the provided model.\n\nNext, we compute the numerical value for the patient using the given data: $\\text{SBP} = 150\\,\\text{mmHg}$ and $\\text{DBP} = 95\\,\\text{mmHg}$.\n$$\n\\text{MAP} = \\frac{1}{3}(150) + \\frac{2}{3}(95)\n$$\n$$\n\\text{MAP} = 50 + \\frac{190}{3}\n$$\nTo combine these terms, we express $50$ as a fraction with a denominator of $3$:\n$$\n\\text{MAP} = \\frac{150}{3} + \\frac{190}{3}\n$$\n$$\n\\text{MAP} = \\frac{150 + 190}{3} = \\frac{340}{3}\n$$\nThe exact value of the Mean Arterial Pressure for this patient is $\\frac{340}{3}\\,\\text{mmHg}$.\n\n**Part 2: Interpretation of Uteroplacental Perfusion**\n\nThe problem provides an Ohm-type relation for Uteroplacental Blood Flow ($UPBF$):\n$$\nUPBF \\approx \\frac{P_{ua} - P_{uv}}{\\text{Uterine Vascular Resistance (UVR)}}\n$$\nwhere the uterine arterial pressure $P_{ua}$ is approximated by $MAP$, and the uterine venous pressure $P_{uv}$ is assumed to be unchanged. The expression becomes:\n$$\nUPBF \\approx \\frac{MAP - P_{uv}}{\\text{UVR}}\n$$\nThe term in the numerator, $MAP - P_{uv}$, represents the perfusion pressure driving blood flow through the uterine vasculature. The term in the denominator, $UVR$, represents the resistance to that flow.\n\nThe patient's blood pressure ($150/95\\,\\text{mmHg}$) meets the diagnostic criteria for a hypertensive disorder of pregnancy (sustained $SBP \\geq 140\\,\\text{mmHg}$ or $DBP \\geq 90\\,\\text{mmHg}$). Our calculation in Part 1 shows an elevated $MAP$ of $\\frac{340}{3}\\,\\text{mmHg} \\approx 113.3\\,\\text{mmHg}$.\n\nWe must consider two effects on $UPBF$:\n1.  **Effect on Perfusion Pressure:** The elevated $MAP$ increases the perfusion pressure ($MAP - P_{uv}$). Viewed in isolation, a higher driving pressure would lead to an *increase* in flow.\n2.  **Effect on Vascular Resistance:** The problem states that a key pathophysiological feature of hypertensive disorders of pregnancy is *increased* Uterine Vascular Resistance ($UVR$) due to endothelial dysfunction and vasoconstriction. This is primarily caused by a failure of the maternal spiral arteries to undergo the necessary physiological remodeling to become low-resistance vessels. An increase in $UVR$ would, in isolation, lead to a *decrease* in flow.\n\nIn the clinical and physiological context of hypertensive disorders like preeclampsia, the pathological increase in $UVR$ is the dominant and primary factor. The systemic hypertension (and thus elevated $MAP$) can be partly understood as a systemic, but ultimately insufficient and maladaptive, compensatory response to maintain perfusion to vital organs in the face of widespread vasoconstriction. The dramatic increase in resistance within the uteroplacental circulation is not overcome by the modest increase in perfusion pressure.\n\nTherefore, the net effect of these two competing factors is a **decrease** in Uteroplacental Blood Flow ($UPBF$). The substantially increased denominator ($UVR$) outweighs the increase in the numerator ($MAP - P_{uv}$), resulting in compromised maternal perfusion to the placenta. This reduction in perfusion is a hallmark of the disease process and underlies many of its fetal complications, such as fetal growth restriction.", "answer": "$$\n\\boxed{\\frac{340}{3}}\n$$", "id": "4451724"}, {"introduction": "A key aspect of managing preeclampsia is accurately assessing its severity, which hinges on identifying evidence of end-organ dysfunction. However, the profound physiological adaptations of pregnancy alter many laboratory reference ranges, creating potential diagnostic pitfalls. This practice problem ([@problem_id:4451711]) provides a case-based scenario to hone your skills in interpreting renal function tests, demonstrating why a patient's own pregnancy baseline is a more sensitive indicator of acute kidney injury than non-pregnant population norms.", "problem": "A $29$-year-old nulliparous patient at $33$ weeks $4$ days presents with new-onset hypertension and mild headache. Two blood pressure measurements taken $4$ hours apart are $152/96$ mm Hg and $148/94$ mm Hg. She denies visual changes, right upper quadrant pain, or dyspnea. Laboratory results today show platelet count $190 \\times 10^{3}$ per $\\mu$L, alanine aminotransferase $28$ U per L, aspartate aminotransferase $31$ U per L, urine protein-to-creatinine ratio $0.6$, and serum creatinine $1.3$ mg per dL. She has no known kidney disease, diabetes, or chronic hypertension. Earlier in pregnancy, at $12$ weeks during routine prenatal testing, her serum creatinine was $0.6$ mg per dL. Urine output in the last $24$ hours has been $1{,}800$ mL.\n\nStarting from fundamental physiologic principles, pregnancy increases renal plasma flow and glomerular filtration rate (GFR) by approximately $40$–$50\\%$ in early gestation, lowering the normal pregnancy serum creatinine reference range compared with nonpregnant values. Preeclampsia is characterized pathophysiologically by widespread maternal endothelial dysfunction, including glomerular endotheliosis that reduces GFR. Contemporary classification systems (for example, those endorsed by the American College of Obstetricians and Gynecologists (ACOG)) define preeclampsia with severe features by the presence of end-organ dysfunction, including renal insufficiency.\n\nUsing only these foundational facts, determine whether the current serum creatinine of $1.3$ mg per dL meets a severe feature criterion for preeclampsia in this patient. Your reasoning must explicitly account for pregnancy physiology and relative change from the patient’s documented pregnancy baseline at $12$ weeks, without assuming any nonpregnant baseline.\n\nWhich option best states the correct classification with justification?\n\nA. Yes; the value exceeds $1.1$ mg per dL and is more than a $2\\times$ increase over the documented pregnancy baseline, indicating renal insufficiency as a severe feature due to reduced GFR from glomerular endotheliosis.\n\nB. No; serum creatinine must reach at least $2.0$ mg per dL or be accompanied by oliguria less than $500$ mL per $24$ hours to qualify as a severe feature.\n\nC. No; the appropriate comparator is a typical nonpregnant baseline (approximately $0.9$ mg per dL), and $1.3$ mg per dL is not a $2\\times$ increase from that baseline.\n\nD. Indeterminate; a $24$-hour urine protein collection is required before any severe feature classification can be made.\n\nE. Yes, but only if systolic blood pressure is at least $160$ mm Hg or diastolic blood pressure is at least $110$ mm Hg; otherwise elevated creatinine does not qualify as a severe feature.", "solution": "Begin with fundamental physiologic and definitional bases:\n\n1. In normal pregnancy, renal plasma flow and glomerular filtration rate (GFR) increase by approximately $40$–$50\\%$ beginning early in gestation. By mass balance, steady-state serum creatinine concentration is inversely related to GFR, so an increased GFR lowers serum creatinine in pregnancy compared with nonpregnant values. Thus, a typical pregnancy baseline serum creatinine is often in the range of approximately $0.4$–$0.8$ mg per dL, lower than a nonpregnant baseline.\n\n2. Preeclampsia pathophysiology includes maternal endothelial dysfunction with glomerular endotheliosis, which reduces GFR and thereby increases serum creatinine relative to the pregnancy baseline.\n\n3. Widely accepted classification criteria (for example, ACOG) define renal insufficiency as a severe feature of preeclampsia if either: serum creatinine is greater than $1.1$ mg per dL, or there is a doubling ($2\\times$) of serum creatinine concentration from the baseline value, in the absence of other renal disease. This criterion does not require severe-range blood pressure or a proteinuria threshold once end-organ dysfunction is present.\n\nApply these to the case:\n\n- The patient’s documented pregnancy baseline at $12$ weeks is $0.6$ mg per dL.\n- The current serum creatinine is $1.3$ mg per dL.\n\nCompute the relative change and compare with thresholds.\n\nAbsolute threshold check:\n- Is current creatinine greater than $1.1$ mg per dL? Since $1.3 > 1.1$, the absolute threshold is exceeded.\n\nRelative (doubling) threshold check:\n- Compute the ratio of current to baseline:\n$$\n\\text{Ratio} \\;=\\; \\frac{1.3}{0.6} \\;=\\; 2.166\\overline{6} \\,.\n$$\n- Since $2.166\\overline{6} \\ge 2.0$, the current value is more than a $2\\times$ increase from the documented pregnancy baseline.\n- Alternatively, compute percent increase:\n$$\n\\%\\ \\text{increase} \\;=\\; \\frac{1.3 - 0.6}{0.6} \\times 100\\% \\;=\\; \\frac{0.7}{0.6} \\times 100\\% \\;=\\; 116.\\overline{6}\\% \\,,\n$$\nwhich exceeds the $100\\%$ increase corresponding to a doubling.\n\nOliguria is not required because either the absolute or relative creatinine criterion suffices for renal insufficiency as a severe feature. The patient’s urine output is $1{,}800$ mL per $24$ hours, which is well above oliguria thresholds. Severe-range blood pressure is also not required for severe feature classification once renal insufficiency is documented.\n\nTherefore, by both absolute and relative criteria, the creatinine value constitutes a severe feature.\n\nOption-by-option analysis:\n\n- Option A: It states that the value exceeds $1.1$ mg per dL and is more than a $2\\times$ increase over the pregnancy baseline, and attributes this to reduced GFR from glomerular endotheliosis. This is consistent with the physiologic basis and the accepted criteria. Verdict — Correct.\n\n- Option B: It imposes a higher absolute threshold ($2.0$ mg per dL) and requires oliguria less than $500$ mL per $24$ hours, neither of which is required by the severe feature definition. Either a serum creatinine greater than $1.1$ mg per dL or a $2\\times$ increase from baseline suffices. Verdict — Incorrect.\n\n- Option C: It wrongly asserts that the comparator must be a typical nonpregnant baseline (approximately $0.9$ mg per dL). In pregnancy, the relevant baseline is the patient’s own pregnancy baseline when GFR is physiologically elevated; the documented value is $0.6$ mg per dL. Using this, the current value is more than a $2\\times$ increase, and it also exceeds the absolute threshold. Verdict — Incorrect.\n\n- Option D: It suggests that a $24$-hour urine protein collection is required to classify severe features. In fact, the presence of end-organ dysfunction such as renal insufficiency defines severe features independent of protein quantification method or amount. Verdict — Incorrect.\n\n- Option E: It states that severe-range blood pressure (systolic at least $160$ mm Hg or diastolic at least $110$ mm Hg) is necessary for an elevated creatinine to qualify as a severe feature. This is false; renal insufficiency itself is a severe feature regardless of blood pressure severity once preeclampsia is diagnosed. Verdict — Incorrect.", "answer": "$$\\boxed{A}$$", "id": "4451711"}, {"introduction": "Once a diagnosis of preeclampsia with severe features is established, the focus shifts immediately to managing acute, life-threatening complications. Prompt and effective control of severe-range hypertension is critical to prevent maternal morbidity, such as stroke. This final exercise ([@problem_id:4451739]) simulates this high-stakes clinical scenario, requiring you to apply an evidence-based, escalating-dose protocol for intravenous labetalol and to calculate the response based on a pharmacodynamic model, thereby translating diagnostic knowledge into decisive therapeutic action.", "problem": "A pregnant patient at $36$ weeks gestation presents with new-onset severe-range hypertension consistent with preeclampsia with severe features. According to the classification of hypertensive disorders of pregnancy, urgent antihypertensive therapy is indicated when systolic blood pressure (SBP) is at least $160$ millimeters of mercury and diastolic blood pressure (DBP) is at least $110$ millimeters of mercury on persistent measurements. The patient’s initial systolic blood pressure (SBP) after $10$ minutes of rest and repeat measurement is $S_{0} = 186$ millimeters of mercury, and the diastolic blood pressure (DBP) is $118$ millimeters of mercury. The goal is to lower SBP below $160$ millimeters of mercury within $30$ minutes to reduce acute maternal risk (for example, intracranial hemorrhage), while maintaining fetal oxygen delivery.\n\nYou initiate intravenous (IV) labetalol per an escalation protocol recommended by professional guidance from the American College of Obstetricians and Gynecologists (ACOG). At time $t=0$ minutes, administer $D_{1} = 20$ milligrams IV labetalol as a bolus over $2$ minutes. If SBP remains at least $160$ millimeters of mercury $10$ minutes after the dose, administer $D_{2} = 40$ milligrams at $t=10$ minutes. If SBP remains at least $160$ millimeters of mercury $10$ minutes later, administer $D_{3} = 80$ milligrams at $t=20$ minutes. Do not exceed a cumulative dose of $220$ milligrams during this sequence.\n\nFor purposes of calculation, adopt the following pharmacodynamic model consistent with low-dose linearity and diminishing incremental response across sequential boluses due to receptor occupancy and baroreflex adaptation. The expected SBP decrease $E_{n}$ measured $10$ minutes after the $n$-th bolus of dose $D_{n}$ (in milligrams) is\n$$\nE_{n} \\;=\\; \\alpha_{n} \\, k \\, D_{n},\n$$\nwhere $k$ is the low-dose effect coefficient in millimeters of mercury per milligram and $\\alpha_{n}$ is an attenuation factor for the $n$-th dose. Assume $k = 0.4$ millimeters of mercury per milligram and $\\alpha_{n} = 1 - 0.1(n-1)$ for $n \\in \\{1,2,3\\}$, so $\\alpha_{1} = 1.0$, $\\alpha_{2} = 0.9$, and $\\alpha_{3} = 0.8$. Let $S_{n}$ denote the SBP measured $10$ minutes after the $n$-th bolus; take $S_{n} = S_{n-1} - E_{n}$ with $S_{0}$ as given.\n\nConstruct the dosing sequence per the above protocol to achieve $SBP  160$ millimeters of mercury within $30$ minutes, and explicitly outline a scientifically appropriate maternal blood pressure measurement schedule and fetal well-being monitoring strategy during this period, including continuous Electronic Fetal Monitoring (EFM) where indicated.\n\nWhat is the minimal cumulative IV labetalol dose (in milligrams) administered by $t=30$ minutes required to attain $SBP  160$ millimeters of mercury under this model? Express your final answer as a single real number in milligrams. No rounding is required.", "solution": "The problem statement is evaluated to be valid. It is scientifically grounded in the clinical management of hypertensive disorders of pregnancy, specifically preeclampsia with severe features. The scenario uses a realistic treatment protocol for intravenous labetalol based on guidelines from the American College of Obstetricians and Gynecologists (ACOG). The pharmacodynamic model, while a simplification, is mathematically well-defined and plausible, incorporating dose-response and diminishing returns. All parameters are provided, rendering the problem self-contained, objective, and well-posed with a unique, computable solution.\n\nThe task is to determine the minimal cumulative dose of intravenous (IV) labetalol required to lower the patient's systolic blood pressure (SBP) to below $160$ millimeters of mercury (mmHg) within $30$ minutes. We will simulate the treatment protocol step-by-step.\n\nFirst, we outline a scientifically appropriate monitoring plan as requested. During acute management of severe hypertension, continuous monitoring is critical.\n1.  **Maternal Monitoring**: Blood pressure and heart rate should be measured every $5$ to $10$ minutes to assess the response to therapy and to avoid iatrogenic hypotension, which could compromise uteroplacental perfusion. The protocol specifies measurements at $10$-minute intervals post-dose.\n2.  **Fetal Monitoring**: Continuous Electronic Fetal Monitoring (EFM) is mandatory to assess fetal well-being. A rapid decrease in maternal blood pressure can reduce blood flow to the placenta, potentially causing fetal distress (manifesting as decelerations in the fetal heart rate, bradycardia, or decreased variability).\n\nThe calculation proceeds by following the specified dosing protocol and pharmacodynamic model. The initial SBP is $S_0 = 186$ mmHg. The model for SBP reduction $E_n$ after the $n$-th dose $D_n$ is $E_n = \\alpha_n k D_n$, with $k = 0.4$ mmHg/mg and $\\alpha_n = 1 - 0.1(n-1)$. The SBP after this reduction is $S_n = S_{n-1} - E_n$.\n\n**At time $t=0$ minutes:**\nThe patient's initial SBP is $S_0 = 186$ mmHg. Since $S_0 \\ge 160$ mmHg, urgent antihypertensive therapy is indicated.\nThe first dose, $D_1 = 20$ mg of IV labetalol, is administered.\nThe cumulative dose at this point is $20$ mg.\n\n**At time $t=10$ minutes:**\nWe evaluate the SBP $10$ minutes after the first dose. For this dose, $n=1$.\nThe attenuation factor is $\\alpha_1 = 1 - 0.1(1-1) = 1 - 0 = 1.0$.\nThe expected SBP decrease is:\n$$E_1 = \\alpha_1 k D_1 = (1.0) \\times (0.4) \\times (20) = 8 \\text{ mmHg}$$\nThe resulting SBP is:\n$$S_1 = S_0 - E_1 = 186 - 8 = 178 \\text{ mmHg}$$\nWe check if the SBP is still in the severe range: $S_1 = 178$ mmHg, which is $\\ge 160$ mmHg.\nAccording to the protocol, since the target is not met, the second dose, $D_2 = 40$ mg, is administered.\nThe cumulative dose is now $D_1 + D_2 = 20 + 40 = 60$ mg.\n\n**At time $t=20$ minutes:**\nWe evaluate the SBP $10$ minutes after the second dose, which was administered at $t=10$ minutes. For this dose, $n=2$.\nThe attenuation factor is $\\alpha_2 = 1 - 0.1(2-1) = 1 - 0.1 = 0.9$.\nThe expected SBP decrease from this dose is:\n$$E_2 = \\alpha_2 k D_2 = (0.9) \\times (0.4) \\times (40) = 14.4 \\text{ mmHg}$$\nThe resulting SBP, calculated from the SBP at the time of this dose administration ($S_1$), is:\n$$S_2 = S_1 - E_2 = 178 - 14.4 = 163.6 \\text{ mmHg}$$\nWe check if the SBP is still in the severe range: $S_2 = 163.6$ mmHg, which is $\\ge 160$ mmHg.\nAccording to the protocol, the target has still not been met. The third dose, $D_3 = 80$ mg, is administered.\nThe cumulative dose is now $D_1 + D_2 + D_3 = 20 + 40 + 80 = 140$ mg.\n\n**At time $t=30$ minutes:**\nWe evaluate the SBP $10$ minutes after the third dose, which was administered at $t=20$ minutes. For this dose, $n=3$.\nThe attenuation factor is $\\alpha_3 = 1 - 0.1(3-1) = 1 - 0.2 = 0.8$.\nThe expected SBP decrease from this dose is:\n$$E_3 = \\alpha_3 k D_3 = (0.8) \\times (0.4) \\times (80) = 25.6 \\text{ mmHg}$$\nThe resulting SBP, calculated from the SBP at the time of this dose administration ($S_2$), is:\n$$S_3 = S_2 - E_3 = 163.6 - 25.6 = 138 \\text{ mmHg}$$\nWe check the therapeutic goal: $S_3 = 138$ mmHg, which is $ 160$ mmHg.\nThe goal of achieving an SBP below $160$ mmHg has been met. No further doses are required at this time.\n\nThe sequence of administered doses was $D_1 = 20$ mg, $D_2 = 40$ mg, and $D_3 = 80$ mg. The therapeutic goal was achieved after the third dose. The minimal cumulative dose required to reach this goal under the specified protocol and model is the sum of these three doses.\n$$D_{\\text{cumulative}} = D_1 + D_2 + D_3 = 20 + 40 + 80 = 140 \\text{ mg}$$\nThis cumulative dose is below the maximum of $220$ mg.", "answer": "$$\\boxed{140}$$", "id": "4451739"}]}